Bionor Pharma ASA is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. The company is also a leader in soy technology and has developed patented products for improved health and prevention of lifestyle-related diseases. It was founded by Cand.med. and Dr.philos. in protein and lipid research, Lars Høie.
| Attributes | Values |
|---|---|
| rdfs:comment |
|
| foaf:name |
|
| foaf:homepage | |
| assets ($) |
|
| equity ($) |
|
| founding date |
|
| founding year |
|
| industry | |
| internationally |
|
| key person | |
| location | |
| net income ($) |
|
| number of employees |
|
| operating income ($) |
|
| product | |
| revenue ($) |
|
| type |